A new treatment for ALS has shown promise in a trial, with reports of improved survival and functional gains. Some outlets specify that certain treatments, such as masitinib and tofersen, have led to improved strength, mobility, and longer survival for some patients. However, it is unclear which specific treatment is being referenced in all cases, as multiple treatments and trials are being reported on simultaneously.